Ascendia Pharmaceutical Solutions: Innovating the Future of CDMO Drug Manufacturing

Jun 26, 2024 12:00:00 AM

Ascendia Pharmaceutical Solution’s Approach to Clinical Trial Materials: A Client-Centric View

May 31, 2024 12:00:00 AM

Empowering Gene Therapy Developers with Tailored Early Formulation Solutions

Apr 29, 2024 12:00:00 AM

Advancing Clinical Trials: Ascendia's Innovative Approach to Achieving 'First in Human'

Apr 17, 2024 12:00:00 AM

Maximizing Pharmaceutical Development with Ascendia's cGMP Manufacturing Services

Mar 25, 2024 12:00:00 AM

Maximizing Opportunities at DCAT Week 2024: A Guide for Biopharma Companies

Mar 12, 2024 12:00:00 AM

CDMO Platform Technologies as They Impact Dosage Formulation Solutions

Feb 13, 2024 12:00:00 AM

Ascendia Pharmaceutical Solutions Expanding Injectable Manufacturing Capabilities in 2024

Jan 31, 2024 12:00:00 AM

Ascendia Pharmaceutical Solutions Offers Increased Flexibility and Customized Solutions in Spray Drying of Poorly Soluble APIs

Nov 22, 2023 12:00:00 AM

Ascendia Pharmaceutical Solutions Named to Inc. 5000 for Fourth Consecutive Year

Aug 24, 2023 12:00:00 AM

Ascendia Expands Sterile/Non-Sterile HQ to Nearly 60,000 Square Feet at NJ Bioscience Center in North Brunswick

Mar 13, 2023 12:00:00 AM